Functional responses and molecular mechanisms involved in histone-mediated platelet activation

Summary

Histones are highly alkaline proteins found in cell nuclei and they can be released by either dying or inflammatory cells. The recent observations that histones are major components of neutrophil extracellular traps and promote platelet aggregation and platelet-dependent thrombin generation have shown that these proteins are potent prothrombotic molecules. Because the mechanism(s) of platelet activation by histones are not completely understood, we explored the ability of individual recombinant human histones H1, H2A, H2B, H3 and H4 to induce platelet activation as well as the possible molecular mechanisms involved. All histones were substrates for platelet adhesion and spreading and triggered fibrinogen binding, aggregation, von Willebrand factor release, P-selectin and phosphatidylserine (PS) exposure and the formation of platelet-leukocyte aggregates; however, H4 was the most potent. Histone-mediated fibrinogen binding, P-selectin and PS exposure and the formation of mixed aggregates were potentiated by thrombin. Histones induced the activation of ERK, Akt, p38 and NFkB. Accordingly, histone-induced platelet activation was significantly impaired by pretreatment of platelets with inhibitors of ERK (U 0126), PI3K/Akt (Ly 294002), p38 (SB 203580) and NFkB (BAY 11–7082 and Ro 106–9920). Preincubation of platelets with either aspirin or dexamethasone markedly decreased fibrinogen binding and the adhesion mediated by histones without affecting P-selectin exposure. Functional platelet responses induced by H3 and H4, but not H1, H2A and H2B, were partially mediated through interaction with Toll-like receptors –2 and –4. Our data identify histones as important triggers of haemostatic and proinflammatory platelet responses, and only haemostatic responses are partially inhibited by anti-inflammatory drugs.

keywords

Histones - platelets - neutrophil extracellular traps - inflammation

^* These authors contributed equally to this work.

• References

• 1 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13: 34-45.
• 2 Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010; 328: 562-564.
• 3 Lindemann S, Kramer B, Seizer P. et al. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007; 5 (Suppl. 01) 203-211.
• 4 Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 1999; 81: 1-7.
• 5 Clark SR, Ma AC, Tavener SA. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463-469.
• 6 Brinkmann V, Reichard U, Goosmann C. et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-1535.
• 7 Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007; 5: 577-582.
• 8 Fuchs TA, Abed U, Goosmann C. et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231-241.
• 9 Luger K, Mader AW, Richmond RK. et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389: 251-260.
• 10 Xu J, Zhang X, Pelayo R. et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009; 15: 1318-1321.
• 11 Zeerleder S, Zwart B, Wuillemin WA. et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003; 31: 1947-1951.
• 12 Massberg S, Grahl L, von Bruehl ML. et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010; 16: 887-896.
• 13 von Bruhl ML, Stark K, Steinhart A. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-835.
• 14 Semeraro F, Ammollo CT, Morrissey JH. et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011; 118: 1952-1961.
• 15 Semeraro N, Ammollo CT, Semeraro F. et al. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis 2010; 2: e2010024
• 16 Fuchs TA, Brill A, Duerschmied D. et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010; 107: 15880-15885.
• 17 Romaniuk MA, Tribulatti MV, Cattaneo V. et al. Human platelets express and are activated by galectin-8. Biochem J 2010; 432: 535-547.
• 18 Negrotto S, Malaver E, Alvarez ME. et al. Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli. J Pharmacol Exp Ther 2006; 319: 972-979.
• 19 Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood 2011; 118: 3708-3714.
• 20 Brill A, Fuchs TA, Savchenko A. et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012; 10: 136-144.
• 21 Frenette PS, Denis CV, Weiss L. et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-1422.
• 22 Sabroe I, Parker LC, Wilson AG. et al. Toll-like receptors: their role in allergy and non-allergic inflammatory disease. Clin Exp Allergy 2002; 32: 984-989.
• 23 Malaver E, Romaniuk MA, D’Atri LP. et al. NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost 2009; 7: 1333-1343.
• 24 Borsch-Haubold AG, Kramer RM, Watson SP. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem 1997; 245: 751-759.
• 25 Favata MF, Horiuchi KY, Manos EJ. et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273: 18623-18632.
• 26 Vlahos CJ, Matter WF, Hui KY. et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269: 5241-5248.
• 27 Arents G, Moudrianakis EN. The histone fold: a ubiquitous architectural motif utilized in DNA compaction and protein dimerization. Proc Natl Acad Sci USA 1995; 92: 11170-11174.
• 28 Marino-Ramirez L, Hsu B, Baxevanis AD. et al. The Histone Database: a comprehensive resource for histones and histone fold-containing proteins. Proteins 2006; 62: 838-842.
• 29 Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2005; 25: 1321-1324.
• 30 Allam R, Scherbaum CR, Darisipudi MN. et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 2012; 23: 1375-1388.
• 31 Gonias SL, Pasqua JJ, Greenberg C. et al. Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3. Thromb Res 1985; 39: 97-116.
• 32 Rivera J, Lozano ML, Navarro-Nunez L. et al. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 2009; 94: 700-711.
• 33 Bishop-Bailey D. The platelet as a model system for the acute actions of nuclear receptors. Steroids 2010; 75: 570-575.
• 34 Caudrillier A, Kessenbrock K, Gilliss BM. et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122: 2661-2671.
• 35 Medina C, Harmon S, Inkielewicz I. et al. Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin. Br J Pharmacol 2012; 166: 938-949.
• 36 Huang H, Evankovich J, Yan W. et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011; 54: 999-1008.
• 37 Pacienza N, Pozner RG, Bianco GA. et al. The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J 2008; 22: 1113-1123.